# Carvedilol for Prevention of Esophageal Varices Progression

> **NCT03736265** · NA · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 240 (actual)

## Conditions studied

- Cirrhosis, Liver
- Portal Hypertension

## Interventions

- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT03736265
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-09
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2022-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03736265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03736265, "Carvedilol for Prevention of Esophageal Varices Progression". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03736265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*